<DOC>
	<DOCNO>NCT00437632</DOCNO>
	<brief_summary>GSK598809 develop innovative treatment substance dependence potentially compulsive behavioral disorder . This study evaluate safety , tolerability pharmacokinetics repeat dos GSK598809 healthy volunteer .</brief_summary>
	<brief_title>Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809</brief_title>
	<detailed_description />
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<criteria>Healthy adult male female subject , age 1850 year inclusive . A female subject eligible participate Nonchildbearing potential Childbearing potential agrees use adequate contraceptive method 90 day postlast dose . Body weight â‰¥50 kg BMI within range 18.529.9 kg/m2 inclusive . Healthy judge responsible physician . No clinically significant abnormality medical , psychiatric laboratory evaluation , include 12lead ECG 24h Holter ECG . Signed date write informed consent admission study . The subject able understand comply Investigator 's instruction requirement restriction protocol The subject positive prestudy breath test alcohol smoking , positive urine drug screen . Drugs screen amphetamine , barbiturate , cocaine , opiates , cannabinoids , benzodiazepine , PCP cotinine . A positive result Hepatitis B surface antigen , Hepatitis C antibody , HIV 1/2 screen visit . Abuse alcohol , define average weekly intake 28 unit ( male ) 21 unit ( female ) , average daily intake 4 unit . 1 unit equivalent half pint ( 285 mL ) beer , 1 measure ( 25 mL ) spirit , 1 glass ( 125 mL ) wine . Liver function test ( LFT ) reference range screen remain elevated repeat ( discuss sponsor , necessary ) . Consumption grapefruit juice grapefruit within 7 day first dose study medication collection final blood sample pharmacokinetic analysis . Subject willing eat standard meal provide CPRU . Participation clinical trial new chemical entity prescription medicine , within previous 3 month . Use prescription nonprescription medicine , include overthecounter remedy , vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) 5 halflives ( whichever longer ) first dose study medication , unless , opinion Investigator Sponsor , medication interfere study procedure compromise subject safety . Loss 400 mL blood 3 month study , e.g . blood donor . History presence allergy study drug drug class , history allergy , opinion responsible physician , contraindicate subject 's participation . Regular use tobacco nicotinecontaining product within 6 month start study . Male subject agree use condom spermicide sexual intercourse pregnant lactating female ; engage sexual intercourse female partner could become pregnant . It strongly recommend addition female also use another form contraception . This criterion must follow time first dose study medication 90 day last dose study medication . History psychiatric diagnosis Axis I Axis II ( DSMIV ) , presence current psychiatric diagnosis base upon psychiatric evaluation . History presence respiratory illness , gastrointestinal , hepatic renal disease , condition know interfere absorption , distribution , metabolism excretion drug . Screening ECG QTc interval &gt; 450 msec and/or PR interval outside range 120220 msec inclusive , ECG suitable QT measurement Semisupine vital sign screen outside range define protocol : Reduction , systolic blood pressure , screening , 20 mm Hg standing ( compare semisupine measurement ) . Personal family history long QT syndrome cardiac conduction disorder , clinically significant cardiac disease . Serum electrolyte concentration outside reference range . The subject serum prolactin exceed normal range . Inability abstain strenuous physical activity 24 h screening , followup , admission ward . Presence history recognise sleep disorder , subject complains sleep disturbance and/or receive treatment sleep disorder , might ( basis medical judgement ) affect pharmacodynamic safety assessment . Inability successfully train test cognition . Additional Criteria Section 3 Consumption coffee , cola caffeine contain drink ( Caffeine one study substrates ) within 4 day precede first dose Consumption charcoalbroiled beef cruciferous vegetable ( e.g . broccoli , cabbage , brussel sprout , cauliflower ) within 7 day prior first dose . This foodstuff know inducer CYP1A2 enzyme</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>repeat dose ,</keyword>
	<keyword>GSK598809</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>tolerability ,</keyword>
	<keyword>placebo ,</keyword>
	<keyword>Safety ,</keyword>
	<keyword>pharmacodynamics ,</keyword>
</DOC>